Category: Decision Maker Content

Health Insurers And 13M Enrollees Cheer Senate’s Extension Of Obamacare Credits

The U.S. Senate’s passage of the Inflation Reduction Act Sunday extends subsidies for millions of Americans who buy individual coverage under the Affordable Care Act known as Obamacare.

InnovationRx: WHO Declares Monkeypox Emergency; Plus: Covid’s Animal Origins

InnovationRx is your weekly digest of healthcare news. Sign up!

Humana Reaps $696 Million Profit On Medicare Growth And Lower Costs

Humana reported nearly $700 million in profits in the second quarter thanks to lower than expected medical and administrative costs.

InnovationRx: General Catalyst’s New Healthcare Fund; Plus: Covid Boosts Diabetes Risk

InnovationRx is your weekly digest of healthcare news. Sign up!

Elevance Health Profits Eclipse $1.6 Billion On Medical And Drug Plan Growth

Elevance Health reported nearly $1.7 billion in second quarter profits as the health insurer formerly known as Anthem grew its diverse portfolio of medical and drug benefits.

Healthcare Illiteracy Remains Rampant Among Americans, New Survey Shows

Efforts to shield Americans from surprise medical bills may be starting to work. But Americans’ gaps in healthcare literacy persist, a new survey shows.

UnitedHealth Group’s Profits Top $5 Billion As Optum And Health Plans Grow

UnitedHealth Group’s profits exceeded $5 billion in the second quarter thanks to a strong performance by its Optum health services and its UnitedHealthcare health insurance plans.

InnovationRx: Healthtech Funding Halftime Report; Plus, Novavax Vaccine EUA

InnovationRx is your weekly digest of healthcare news. Sign up!

Long Covid And Its Unequal Burden

The heightened probability of infection, reduced access to primary/specialized care, and diminished economic position faced by minority populations will translate to a more arduous road to Long Covid recovery.

Despite Scrutiny, Health Insurers Already Looking To Expand Medicare Advantage For 2023

Health insurers are expanding their Medicare Advantage markets for 2023 despite uncertain financial markets and scrutiny of certain business practices.